Advertisement
Screener

Foamix Pharmaceuticals Ltd. Operating Leases, Rent Expense, Net

Foamix Pharmaceuticals Ltd. Operating Leases, Rent Expense, Net

Foamix Pharmaceuticals Ltd. reported Operating Leases, Rent Expense, Net of $794.00 thousand for the 12-month period ending 2019-12-31, per its 10-K filed 2020-03-12.

Discontinued › Expense Statement › Operating Expenses

us-gaap:OperatingLeasesRentExpenseNet · last filed 2020-03-12

  • Foamix Pharmaceuticals Ltd. operating leases, rent expense, net for the quarter ending 2018-12-31 was $191.00K, a 3.80% increase year-over-year.
  • Foamix Pharmaceuticals Ltd. operating leases, rent expense, net for the quarter ending 2018-09-30 was $191.00K, a 3.80% increase year-over-year.
  • Foamix Pharmaceuticals Ltd. operating leases, rent expense, net for the quarter ending 2018-06-30 was $195.00K, a 16.07% increase year-over-year.
  • Foamix Pharmaceuticals Ltd. operating leases, rent expense, net for the quarter ending 2018-03-31 was $195.00K, a 78.90% increase year-over-year.
  • Foamix Pharmaceuticals Ltd. operating leases, rent expense, net for fiscal 2019 was $794.00K, a 2.85% increase from fiscal 2018.
  • Foamix Pharmaceuticals Ltd. operating leases, rent expense, net for fiscal 2018 was $772.00K, a 19.69% increase from fiscal 2017.
  • Foamix Pharmaceuticals Ltd. operating leases, rent expense, net for fiscal 2017 was $645.00K, a 80.17% increase from fiscal 2016.
  • Foamix Pharmaceuticals Ltd. operating leases, rent expense, net for fiscal 2016 was $358.00K, a 1.70% increase from fiscal 2015.
Period endOperating Leases, Rent Expense, Net 3 monthOperating Leases, Rent Expense, Net 6 monthOperating Leases, Rent Expense, Net 9 monthOperating Leases, Rent Expense, Net 12 month
2019-12-31$794.00K
10-K · filed 2020-03-12
2018-12-31$191.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-28
$382.00K
derived: sum of 2 quarters · filed 2019-02-28
$577.00K
derived: sum of 3 quarters · filed 2019-02-28
$772.00K
10-K · filed 2019-02-28
2018-09-30$191.00K
10-Q · filed 2018-11-07
$386.00K
derived: sum of 2 quarters · filed 2018-11-07
$581.00K
10-Q · filed 2018-11-07
$765.00K
derived: sum of 4 quarters · filed 2019-02-28
2018-06-30$195.00K
10-Q · filed 2018-08-08
$390.00K
10-Q · filed 2018-08-08
$574.00K
derived: sum of 3 quarters · filed 2019-02-28
$758.00K
derived: sum of 4 quarters · filed 2019-02-28
2018-03-31$195.00K
10-Q · filed 2018-05-08
$379.00K
derived: sum of 2 quarters · filed 2019-02-28
$563.00K
derived: sum of 3 quarters · filed 2019-02-28
$731.00K
derived: sum of 4 quarters · filed 2019-02-28
2017-12-31$184.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-28
$368.00K
derived: sum of 2 quarters · filed 2019-02-28
$536.00K
derived: sum of 3 quarters · filed 2019-02-28
$645.00K
10-K · filed 2019-02-28
2017-09-30$184.00K
10-Q · filed 2018-11-07
$352.00K
derived: sum of 2 quarters · filed 2018-11-07
$461.00K
10-Q · filed 2018-11-07
2017-06-30$168.00K
10-Q · filed 2018-08-08
$277.00K
10-Q · filed 2018-08-08
2017-03-31$109.00K
10-Q · filed 2018-05-08
2016-12-31$358.00K
10-K · filed 2019-02-28
2016-06-30$73.00K
6-K · filed 2017-08-08
$174.00K
6-K · filed 2017-08-08
2015-12-31$352.00K
10-K · filed 2018-03-01
2015-06-30$87.00K
6-K · filed 2016-08-10
$176.00K
6-K · filed 2016-08-10
2014-12-31$172.00K
20-F · filed 2017-02-21
2014-06-30$72.00K
6-K · filed 2015-10-19
2013-12-31$180.00K
20-F · filed 2016-03-02
2012-12-31$198.00K
20-F · filed 2015-03-17